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Abstract 
Cushing’s syndrome (CS) causes hypogonadotropic hypogonadism and anovulatory infertility due to hypercortisolism, and it is very 
rare in pregnancy. CS in pregnancy is associated with important maternal-foetal morbidity and mortality, such as preeclampsia and 
premature delivery. 
A systematic search was conducted in the MEDLINE library to retrieve articles reporting cases of CS in pregnant women, during the 
period between 2010 and 2020. 
Thirty-five reported cases are presented focusing on the ability of diagnosis, treatment therapies, and foetal outcomes.
Diagnosis of CS during pregnancy can be challenging and is often delayed, adrenal adenoma being the predominant cause. Both medical 
treatment and surgery aiming at restoring the cortisol balance reduce maternal and foetal complications. (Endokrynol Pol 2021; 72 (1): 64–72)
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Introduction 
Cushing’s syndrome (CS) results from prolonged ex-
posure to high levels of glucocorticoids. Being a rare 
syndrome, CS has an incidence in the general popula-
tion of about 40–70 per million every year, affecting 
mainly adults, and especially women usually aged 30 to 
50 years [1]. The most common cause is the administra-
tion of excessive doses of glucocorticoids resulting in 
iatrogenic or exogenous syndrome. On the other hand, 
endogenous Cushing syndrome has a low incidence 
up to 0.7–2.4 per million population per year and can 
be further classified as adrenocorticotropic hormone 
(ACTH)-dependent (80–85% of cases) or ACTH-inde-
pendent (15–20%) [2]. The vast majority of ACTH-de-
pendent Cushing syndrome is caused by a pituitary 
adenoma that produces high levels of ACTH, thus 
leading to extreme cortisol production by the adrenal 
glands (Cushing disease). Other causes include ectopic 
ACTH or corticotropin-releasing hormone (CRH) re-
lease, which are related to multiple endocrine neoplasia 
type 1, small-cell carcinoma of the lung or pulmonary 
carcinoid tumour, pancreatic neuroendocrine tumours 
(NETs), thymic NETs, gastrinomas, medullary thyroid 
cancer, and pheochromocytoma. ACTH-independent 
causes of endogenous Cushing syndrome include ad-
renal tumours (adenoma or carcinoma) and macro- or 
micronodular adrenal hyperplasia [3]. 
Cushing syndrome in pregnancy is exceptionally 
rare because hypercortisolism can lead to hypogo-
nadotropic hypogonadism, impaired ovulation, and 
consequently infertility. The predominant aetiology of 
CS in pregnant women is adrenal adenoma (in 40–60% 
of the cases). A diagnosis of Cushing syndrome in preg-
nancy is difficult and is often delayed due to an overlap 
between symptomatology and the physiological effects 
of pregnancy such as hypertension, hyperglycaemia, 
weight gain, striae, and mood changes [4] (Fig. 1).
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ing on Cushing’s syndrome in pregnant women during 
the period between 2010 and 2020. The search strategy 
was based on the use of keywords such as Cushing’s 
syndrome, pregnancy, and hypercortisolism. The 
PRISMA approach was used for the selection of the 
publications included in the review. A total of 102 re-
cords were identified. Following removal of the dupli-
cates, the publications that could not be electronically 
retrieved, and the reviews, 32 records remained. The 
full-text articles assessed for eligibility amounted to 32, 
and none of them was excluded. The inclusion process 
is presented in Figure 2. 
Table 1 summarises all case reports used in the 
review.
A review of reported cases
Herein, we reviewed the literature during the period 
between 2010 and 2020 and described a range of 35 
pregnant women diagnosed with CS. Despite the 
published case reports and reviews, knowledge in this 
field is rather limited because CS in pregnant women 
is extremely rare.  
Concerning the aetiology of Cushing’s disease 
in pregnant women, it is reported that adrenal ad-
enoma is the main cause, contrary to adenoma of the 
pituitary gland [5]. The cases presented in this review 
are in agreement with existing literature because ap-
proximately 80% of the patients presented an adrenal 
Pregnant women normally have increased levels of 
CRH, ACTH, and cortisol secreted mainly by the placenta 
and the hypothalamic-pituitary-adrenal axis (HPA) ac-
tivation during the first trimester. More specifically, ac-
cording to recent clinical data serum cortisol is expected 
to rise up to 1.6-fold by the 11th week of gestation while 
urinary free cortisol can increase up to three times the 
normal range. Moreover, the placental secretion of ACTH 
and CRH can lead to non-decreased ACTH levels in 50% 
of women with adrenal CS and attenuated response 
to dynamic tests such as CRH test, desmopressin test, 
and high-dose dexamethasone suppression test. One 
additional restriction is found in the used imaging mo-
dalities because only ultrasound and MRI are preferred 
and the use of gadolinium is contraindicated in most 
cases [5]. Taking all the above mentioned into account, 
it is easily assumed that accurate diagnosis of Cushing 
syndrome during pregnancy can be very challenging, 
thus complicating the appropriate and early treatment of 
these patents, which is vital for preventing the morbidity 
associated for both the mother and the foetus.
Herein, we review published cases in the literature 
about pregnant women with CS, aiming to investigate the 
different causes and treatment options of CS in pregnancy.
MedlIne library systemic research
A systematic search was conducted in the MEDLINE 
(via PubMed) library in order to retrieve articles focus-
— adrenal carcinomas are reported in less than 
10% cases
Aetiology:
— adrenal adenoma reported in 40–60% cases, 
in contrast to non-pregnant women for whom 
the most frequent cause is Cushing disease
— pituitary adenomas represent 15–40% of cases
Laboratory methods for diagnosis:
— low-dose dexamethasone suppression test: false 
positive due to oestrogen-induced CBG 
— 24-h urinary free cortisol: consider more than 
> 3  ULNR in the second/third trimester
— late night salivary cortisol: consider more than 
> 2–3  × ULNR
— US adrenals and/or non-contrast MRI adrenals
Imaging modalities:
— non-contrast MRI pituitary
— medical management for those not t for surgery: 
metyrapone, ketoconazole, cabergoline
Treatment:
st nd— surgery 1  line (2  trimester)
Cushing syndrome 
in pregnancy
Figure 1. General characteristics of Cushing syndrome in pregnancy [4, 11]. ULNR — upper limit of normal range; MRI — magnetic 
resonance imaging; US — ultrasound scan; CBG — corticosteroid-binding globulin
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adenoma. This may be attributed to the fact that pa-
tients with an adrenal adenoma are most likely to be 
purely cortisol producing, thus their ovulatory function 
remains unaffected. Alternatively, pregnancy-induced 
hCG levels might have triggered a pre-existing subclini-
cal CS in these patients due to the aberrant expression 
of LH receptors in adrenocortical cells of an adrenal 
adenoma, whereas pre-pregnancy LH levels might be 
insufficient for the development of CS [6].
A high rate of maternal complications may arise 
from uncontrolled CS during pregnancy. Even in 
treated cases, some patients develop complications 
such as preeclampsia or premature delivery. The most 
commonly described maternal complications include 
the following: hypertension (68%), diabetes (25%), 
preeclampsia (14%), osteoporosis and fractures (5%), 
heart failure (3%), and maternal death (2%). The most 
common foetal complication is prematurity (43%), fol-
lowed by intrauterine growth restriction (21%), stillbirth 
(6%), spontaneous abortion or intrauterine death (5%), 
and hypoadrenalism (2%) [7]. However, higher foetal 
survival rates were observed in women treated during 
pregnancy [8].
Given that Cushing’s disease is linked to high 
morbidity, early diagnosis and effective treatment are 
important. Concerning the diagnosis of this syndrome, 
it can be difficult and demanding during pregnancy 
because the typical features of the syndrome and the 
pregnancy can overlap. According to existing literature, 
analysis and measurement of the urinary cortisol level 
and circadian rhythm of plasma cortisol constitutes 
an effective strategy to detect Cushing’s syndrome dur-
ing pregnancy. Late-night salivary cortisol is reported in 
various cases to be the best approach to detect patients 
with endogenous hypercortisolism [5]. A more diffi-
cult approach for the diagnosis of CS is the overnight 
dexamethasone suppression test, which evaluates 
clinical hypercortisolism in patients presenting adre-
nal incidentalomas. An alternative diagnosis involves 
pheochromocytoma and primary aldosteronism. In the 
majority of the cases presented in this review adenoma 
was detected via magnetic resonance imaging. There-
fore, magnetic resonance imaging can be considered 
as a useful tool for identifying this syndrome caused 
by adrenal incidental tumours during pregnancy [9]. 
However, it is essential that new clinical studies, using 
additional techniques and predictors targeting the rec-
ognition of Cushing syndrome, are conducted. 
Concerning the treatment of Cushing syndrome, 
the most commonly recommended strategy is surgery 
Figure 2. Prisma flow diagram for the current review
























Records identied through 
database search 
(n = 102)
Additional records identied 
through other sources 
(n = 0)
Records after duplicates removed 
(n = 102)
Record screened (n = 102) Records excluded (n = 70)
Full text articles assessed 
for eligibility 
(n = 32)






















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































treatment [5]. In almost 80% of the cases in this review, 
surgery was the treatment option. Whatever the type of 
the surgery (pituitary or adrenal), the period between 
the end of the first trimester and the beginning of early 
second trimester is considered as the most appropri-
ate, being associated with fewer maternal and foetal 
complications [10]. Some case reports showed the 
possibility of surgery during the third trimester, with 
a higher risk of prematurity. For instance, laparoscopic 
adrenalectomy for CS in pregnancy was found to be 
a safe and efficacious procedure up to 32 weeks of gesta-
tion, leading to a reduction in perinatal mortality and 
maternal morbidity rates, but with little effect on the 
occurrence of preterm birth and intrauterine growth 
restriction [11]. There are very limited data on the ef-
ficacy and the risks induced by bilateral adrenalectomy 
for hypercortisolism during pregnancy: if this option 
is chosen, the ideal time frame is the same as for uni-
lateral adrenalectomy. Physicians should keep in mind 
that patients treated surgically for hypercortisolism are 
likely to have adrenal insufficiency for the rest of the 
pregnancy.
Apart from that, medical management is often used, 
aiming to control the cortisol excess for those who are 
not eligible for surgery or have had failure of surgery. 
Antisteroidogenic agents, such as metyrapone have 
been found to be effective at controlling hypercorti-
solism, but they may worsen hypertension because 
of deoxycorticosterone accumulation, thus increasing 
the frequency of preeclampsia. Metyrapone also passes 
through the placental barrier and may thus affect foetal 
adrenal steroid synthesis [12]. Ketoconazole has been 
used less as a therapeutic option and has not caused 
any complications to the foetus and the mother during 
pregnancy in the cases reported. However, one should 
take the potential teratogenicity and increased rate of 
abortion observed in animal studies into consideration 
[4]. Additionally, cabergoline was used in various cases 
of Cushing disease as an alternative option. Indeed, in 
two reported cases, a pregnancy was obtained while 
on high-dose cabergoline and maintained throughout 
pregnancy with complete remission [13, 14]. There are 
no reports of use of pasireotide during pregnancy and 
mitotane contraindicated due to a risk of teratogenicity. 
Conclusions
In conclusion, Cushing’s syndrome is extremely rare 
during pregnancy, with limited cases to be reported in 
literature. Diagnosis of CS in pregnancy is considered 
as a demanding task, and early recognition is important 
for maternal and foetal outcome. There is no consensus 
on the management of CS during pregnancy, and the 
individualised risk-benefit ratio should be considered.
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